Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Liberian medic treated with experimental Ebola drug dies

25 August 2014, 15:59

Monrovia -A Liberian doctor treated with experimental American anti-Ebola serum ZMapp has died, the west African nation said on Monday.

Abraham Borbor had been improving but died on Sunday night, Liberian Information Minister Lewis Brown told AFP.

"He was showing signs of progress but he finally died. The government regrets this loss and extends its condolences to the bereaved family," Brown said.

Two other health workers receiving the serum are still in treatment, said the minister, adding that there were "signs of hope".

The World Health Organization (WHO) said on Thursday there had been a "significant improvement" in the condition of a doctor and nurse being treated with ZMapp in Liberia, and that another doctor was getting better, but still in a serious condition.

Liberia took delivery of ZMapp on August 13 from the United States, which gave the serum to two US citizens who were declared cured last week.

The Americans were infected in Liberia along with a Spanish priest who died on August 12, despite also receiving ZMapp.

The very small available stocks of ZMapp, which has never been through clinical trials on humans, have now been used up, according to the lab that produces it.

The WHO has been discussing the use of unapproved drugs as a way of getting a handle on an outbreak in Africa that has already cost more than 1,400 lives.

There is currently no available cure or vaccine for Ebola, but several drugs are under development.

Tokyo said on Monday it was ready to offer an experimental drug developed by a Japanese company to help stem the global tide of Ebola.

Avigan, which is taken in tablet form, was approved as an anti-influenza drug in Japan in March and is currently in clinical tests in the United States.

A panel of medical experts convened by the WHO earlier this month determined it was "ethical" to provide experimental treatments, given the scale of the epidemic.



Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Submitted by
George Vodongo
China to help Kenya fight high le...

China observed that if left unchecked, corruption could see the country degenerate into lawlessness. Read more...

Submitted by
S Mbinya
Signs that he is seeing someone e...

When a man wants to be with you, he will always create time to be with you. Read more...

Submitted by
George Vodongo
Spat between DP Ruto and Boniface...

A close associate of the DP, Hon Njogu Barua made an alarming comment on live TV Tuesday morning. Read more...

Submitted by
Ben Wangui
Matatu driver who drugged, robbed...

The driver of a Nissan matatu who over the weekend drugged and robbed a female passenger in Nairobi has been charged. Read more...

Submitted by
Gabriel Ngallah
Heavy police contingent deployed ...

More police officers were on Monday deployed at Likoni in Mombasa County in a security operation to nab members of the ‘Wakali Kwanza’ and ‘Mtalia’ criminal gangs who have been terrorizing locals in the area. Read more...

Submitted by
Ben Wangui
Man released on Presidential amne...

He was caught taking money from a church offering bag at Ol Jabet Independent Pentecostal Church in Laikipia West on October 23. Read more...